Procedure
Intracept Procedure
Intracept Procedure is a medical procedure with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
4
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
100%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Terminated(1)
Detailed Status
Completed1
Active, not recruiting1
Enrolling by invitation1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (100.0%)
Trials by Status
completed125%
active_not_recruiting125%
enrolling_by_invitation125%
terminated125%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruiting
Intracept Intraosseous Basivertebral Nerve Ablation
NCT05660512
completed
CLBP Single-Arm Long-Term Follow-up Study
NCT05207813
enrolling_by_invitationphase_4
Basivertebral Nerve Ablation With the Intracept Procedure
NCT05692440
terminated
The Intracept Global Registry ( TIGR ) - Pilot Study
NCT04449835
Clinical Trials (4)
Showing 4 of 4 trials
NCT05660512
Intracept Intraosseous Basivertebral Nerve Ablation
NCT05207813
CLBP Single-Arm Long-Term Follow-up Study
NCT05692440Phase 4
Basivertebral Nerve Ablation With the Intracept Procedure
NCT04449835
The Intracept Global Registry ( TIGR ) - Pilot Study
All 4 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 4